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Impaired Nitric Oxide-Mediated Flow-Induced
Dilation in Arterioles of
Spontaneously Hypertensive Rats
Akos Koller, An Huang
Abstract We tested the hypothesis that impairment of
flow-dependent dilator mechanisms of skeletal muscle arteri-
oles is one of the underlying reasons for the increased periph-
eral resistance in hypertension. Isolated, cannulated arterioles
(z55 ,um) of gracilis muscle of 12-week-old spontaneously
hypertensive (SH) and normotensive Wistar (NW) rats were
investigated. At a constant perfusion pressure (80mm Hg), the
active diameters of NW and SH arterioles were 57.7+ 1.9 and
51.5+±3.2 ,um, whereas their passive diameters (Ca2-free
solution) were 113.6+2.9 and 101.7±2.9 ,um, respectively.
Flow-induced dilation was elicited by increases in flow of the
perfusion solution from 0 to 25 ,L/min in 5-,uL/min steps. This
response was significantly less in arterioles of SH compared
with NW rats. For example, at 25--gL/min flow, the diameter of
arterioles of SH rats was -%56% less (P<.05) than those of NW
rats. Indomethacin, an inhibitor of prostaglandin synthesis,
n vivo studies of the microcirculation of skeletal
muscle in hypertension have demonstrated a vari-
ety of structural changes1-4 that are thought to
contribute to the maintenance of increased peripheral
vascular resistance.4 In addition, previous in vitro stud-
ies5-8 demonstrated changes in the vasoactive function
of large arteries in various forms of hypertension. For
example, a reduced dilation to acetylcholine and to
other endothelium-dependent substances was shown to
be present in hypertension, indicating an impairment in
the function of endothelium to produce dilator fac-
tors.5-8 Although studies investigating the dilator func-
tion of microvessels are sparse in hypertension,9"10 it was
demonstrated in skeletal muscle arterioles of Dahl
salt-sensitive rats that there is a deficiency in the basal
production of nitric oxide,9 known to be produced in the
endothelium of arterioles.1"-'4
It seems well established that the vascular endothe-
lium has an important role in the regulation of skeletal
muscle microcirculation via the production and release
of dilator factors to a variety of stimuli.'3-16 The pres-
ence and importance of a flow-induced dilator mecha-
nism has also been demonstrated in vivo and in vitro in
skeletal muscle arterioles of normotensive rats. Further-
more, it was shown that this mechanism depends on the
intact function of the endothelium.15,16 The presence
and possible alterations of flow-induced dilation of
significantly attenuated the flow-diameter curve in both strains
of rats. In contrast, N"-nitro-L-arginine, a nitric oxide synthase
inhibitor, significantly shifted the flow-diameter curve to the
right in NW rats, but it did not affect the flow-diameter curve
in SH rats. Thus, the present findings demonstrate that in
gracilis muscle arterioles of normotensive rats in response to
increases in flow (shear stress), prostaglandins and nitric oxide
are coreleased, resulting in a dilation. In early hypertension,
however, there is a reduced arteriolar dilation to increases in
flow that is due to the impairment of the nitric oxide-mediated
portion of the flow-dependent arteriolar dilation. (Circ Res.
1994;74:416-421.)
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skeletal muscle arterioles, however, have not yet been
investigated in hypertension.
We hypothesized that in hypertension there is an
impairment of the flow-sensitive vasodilator mechanism
and that impairment of this mechanism could contribute
to the enhanced peripheral resistance.
The aim of our in vitro study, therefore, was (1) to
establish, in arterioles of gracilis muscle of both nor-
motensive and hypertensive rats, the nature and the
mediation of the vascular response after an increase in
perfusate flow and (2) to test the hypothesis that
flow-dependent dilation is impaired in hypertension,
and if so, to delineate the reason for the alteration.
To test our hypothesis, we investigated the changes in
diameter as a function of perfusate flow (in the presence
of a constant intravascular pressure) in isolated gracilis
arterioles of normotensive and spontaneously hyperten-
sive rats. In addition, the possible role of endothelial
factors in the development and/or modulation of flow-
induced dilation was assessed by the use of pharmaco-
logical agents affecting the synthesis of endothelium-
derived relaxing factor/nitric oxide and prostaglandins.
Materials and Methods
Experiments were conducted on isolated arterioles (":'55
,um) of gracilis muscle of 12-week-old male normotensive
Wistar (NW) and spontaneously hypertensive (SH) rats. Sys-
tolic blood pressure was measured by the tail-cuff method.
Rats were anesthetized with intraperitoneal injections of so-
dium pentobarbital (Nembutal sodium, 50 mg/kg). The isola-
tion procedure of gracilis muscle arterioles has been described
previously.14 17Briefly, the gracilis muscle of rats was exposed
by an incision in the skin. The muscle then was cut out and
placed on a Petri dish containing cold (0°C to 4°C) salt solution
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(pH 7.4) composed of, in mmol/L: NaCI 145, KCl 5.0, CaCl2
2.0, MgSO4 1.0, NaH2P04 1.0, dextrose 5.0, pyruvate 2.0,
EDTA 0.02, and 3-N-morpholino-propane sulfonic acid
(MOPS) 3.0. The muscle was pinned to the silicone bottom of
the dish and allowed to equilibrate for z15 minutes. Rats were
euthanized by an overdose of sodium pentobarbital.
With microsurgery instruments and an operating micro-
scope (Olympus), a segment 1 mm long of an arteriole
branching off from the main arteriole supplying the muscle was
isolated from the gracilis muscle and surrounding tissue and
transferred to the vessel chamber. The chamber contained a
pair of glass micropipettes filled with physiological salt (PS)
solution at room temperature. The PS solution used for
suffusion and perfusion of the vessels contained, in mmol/L:
NaCl 110.0, KCl 5.0, CaCl2 2.5, MgSO4 1.0, dextrose 10.0,
NaHCO3 24.0, and EDTA 0.02 and was equilibrated with a gas
mixture of 21% 02/5% C02, balanced with N2, at pH 7.4
(37°C). From a reservoir, the vessel chamber (15 mL) was
continuously supplied with PS solution at a rate of 40 mL/min.
After the vessel was mounted on the proximal pipette and
secured with sutures, the perfusion pressure was raised to 20
mm Hg to clear the clotted blood from the lumen; then, the
other end of the vessel was mounted on the distal pipette. As
described previously,18 both proximal (inflow) and distal (out-
flow) micropipettes were connected with silicone tubing to a
pressure-servo syringe system (Living Systems Inc, Burlington,
Vt). The system was arranged to have mirror symmetry, so that
the axis of symmetry was located perpendicularly at the middle
of the arteriolar segment. Only pipettes with similar dimen-
sions and equivalent resistances to flow were used, as assessed
by the changes in perfusion pressure in response to increments
of flow by a Harvard perfusion pump. This resulted in equal
resistances (R, and R2) of the two sides of the system (from
pressure transducer to the tip of the pipette).
To flush the vessel and cannulas, the system was perfused
for several minutes. Then, the perfusion pressure was slowly
(over -t1 minute) increased to 80 mm Hg. At this time, the
pressure-servo system was placed in the manual mode (ie, no
automatic maintenance of pressure) to ascertain that there
were no leaks in the system. If no leaks were detected (ie,
perfusion pressure remained constant), the pressure-servo
system was set in the automatic mode. The temperature was
set to 37°C (YSI temperature controller), and the vessels were
allowed to equilibrate for about 1 hour.
Experimental Procedure
In all protocols, only those vessels that developed sponta-
neous tone to pressure were used, since no vasoactive agent
was added to the PS solution. After the equilibration period,
flow-diameter relations were obtained in control conditions in
both strains of rats. Perfusate flow was increased from 0 to 25
/uL/min in 5 -gL/min steps. Flow was established at a constant
intravascular pressure (80 mm Hg) by changing proximal and
distal pressures to an equal degree but in opposite directions
to keep midpoint luminal pressure constant. The flow was
measured by a ball flowmeter (Omega) calibrated by a Har-
vard perfusion pump in which flow rate was accurate in the
range of 0 to 100 ,uL/min. Each flow step was maintained for
-5 minutes to allow the vessels to reach steady-state condi-
tions before the diameter of the arterioles was measured.
After the flow-diameter relation was obtained, flow was
stopped; then, after =20 minutes, responses of arterioles to
vasoactive agents were tested.
In the first experimental series, the role of prostaglandins in
flow-induced dilation of gracilis muscle arterioles was as-
sessed. After control responses were obtained, indomethacin
(10-5 mol/L) was added to the suffusion solution to inhibit the
synthesis of prostaglandins.13"16,18 After an incubation period
of =30 minutes, the flow-diameter relations were once more
assessed. To assess the efficacy and specificity of this inhibitor,
arteriolar responses to arachidonic acid (10` mol/L) and
prostaglandin E2 (10`8 mol/L) were obtained before and after
the vessels were exposed to indomethacin.
In the second series of experiments, after control flow-
diameter curves were obtained, the vessels were subjected to
Nw-nitro-L-arginine (L-NNA, 10` mol/L), an inhibitor of
nitric oxide synthesis.'9'20 Then, after an 'z15-minute incuba-
tion period, changes in diameter in response to step increases
in perfusate flow were reassessed. The efficacy and specificity
of this inhibitor were assessed by arteriolar responses to
acetylcholine (10`8 mol/L) and sodium nitroprusside (10`
mol/L), known to be endothelium-dependent and -indepen-
dent dilator agents, respectively,1"-'4 before and after the
vessels were exposed to L-NNA. In this experimental series,
after control responses and responses in the presence of
L-NNA were obtained, indomethacin was administered and
the flow-diameter relation was again determined.
Responses to vasoactive agents were tested at 80 mm Hg
perfusion pressure in no-flow conditions. All drugs were added
to the reservoir connected to the vessel chamber, and final
concentrations are reported. After responses to each drug
subsided, the vessel chamber was flushed with PS solution. To
assess the active tone generated by the arterioles in response
to intravascular pressure, at the conclusion of each experi-
ment, the suffusion solution was changed to a Ca 2k-free PS
solution that contained sodium nitroprusside (10-4 mol/L) and
EGTA (1.0 mmol/L). The vessels were incubated for 10
minutes, then the passive diameter of arterioles at 80 mm Hg
perfusion pressure was obtained. The diameters of vessels and
peak responses in various experimental conditions were mea-
sured with an image shearing monitor (model 907, IPM, San
Diego, Calif) and recorded with an X-Y recorder (Multi-
corder, MC6625).
All salts and chemicals were obtained from Sigma Co or
Aldrich Co and were prepared on the day of the experiment.
Changes in diameter in response to vasoactive agents were
normalized to the corresponding passive diameter and ex-
pressed as percent changes. Results are presented as
mean+SEM. N and n refer to the number of rats and vessels,
respectively. Statistical analyses were done by analysis of
variance, followed by Tukey's post hoc test, regression analysis,
and paired and grouped Student's t tests, as appropriate. A
value of P<.05 was considered significant.
Results
The systolic blood pressures of NW and SH rats were
105.0+3.1 (N=6) and 200.0±2.9 (N=7) mm Hg, respec-
tively, showing a significant increase in blood pressure in
hypertensive compared with normotensive rats.
The active diameters of arterioles of NW and SH rats
obtained in the presence of constant intravascular pres-
sure (80 mm Hg) and static flow conditions were not
significantly different (57.7±1.9 and 51.5±3.2 gim, re-
spectively). In the same conditions but in Ca2-free
solution, the passive diameter of each arteriole was also
obtained (see "Materials and Methods"). We found
that the mean passive diameters of NW and SH vessels
were significantly different (113.6+2.9 and 101.7±2.9
gim, respectively; P<.05), but the active vessel diame-
ters, expressed as a percent of passive diameter, were
not different in the two strains of rats (50.9±1.4% and
50.7±2.5%).
Fig 1 demonstrates the changes in the diameter of
arterioles of NW and SH rats in response to step
increases in flow in control conditions. From 5--gL/min
perfusate flow, the diameter of arterioles of SH rats
started to deviate significantly (P<.05) from that of NW,
and at 25-giL/min flow, the diameter of SH arterioles
was ~'z56% less than that of NW. Also, the significant
difference in the slope of flow-diameter curves indicates
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FIG 1. Graph showing arteriolar diameter (mean+±SEM) of
normotensive Wistar (N [rats] = 11/n [vessels] = 12) and sponta-
neously hypertensive rat (N=12/n=12) gracilis muscle as a
function of perfusate flow. The slopes of the regression lines are
significantly different: NW, y=1 .69x+59.9 (r= .993) and SH,
y=0.77x+51.2 (r=.989). *Significant differences (P<.05) be-
tween hypertensive and normotensive rats.
that arterioles of SH rats have a reduced dilation to step
increases in perfusate flow compared with the arterioles
of normotensive rats.
Next we investigated the endothelial mechanism(s)
responsible for the mediation of flow-induced dilation
of arterioles of NW and SH rats. First we examined the
role of prostaglandins in the flow-induced dilation by
obtaining this response in the presence of indometh-
acin. We found that dilator responses of arterioles to
arachidonic acid and prostaglandin E2 were not signifi-
cantly different in SH compared with NW rats (Table).
The efficacy and specificity of the inhibition of cyclo-
oxygenase by indomethacin is indicated by the elimina-
tion of the dilation to arachidonic acid in both strains of
rats, whereas the dilation to prostaglandin E2 was not
affected (Table). Indomethacin did not affect basal
diameter but significantly reduced the dilation to in-
creases in perfusate flow in arterioles of both strains of
rats (Fig 2, upper and lower panels). In NW rats the
reduction of the maximum response was 48%, whereas
in SH rats it was 79%.
To examine the involvement of nitric oxide in the
flow-induced response, we used an L-arginine analogue
after obtaining control responses. In control conditions,
we found that dilator responses of arterioles to acetyl-
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FIG 2. Top, Graph showing arteriolar diameter (mean±SEM) of
normotensive Wistar rat gracilis arterioles (N [ratsl=5/n [ves-
sels] =5) as a function of perfusate flow in control conditions and
in the presence of indomethacin (INDO, 10-5 mol/L) in the
suffusate. The slopes of regression lines are significantly differ-
ent (P<.05): control, y=1.7x+64.6 (r=.975); INDO,
y=0.96x+64.6 (r=.973). Bottom, Graph showing changes in
diameter (mean±SEM) of spontaneously hypertensive rat graci-
lis arterioles (N=5/n=5) as a function of perfusate flow in control
conditions and in the presence of indomethacin (INDO, 10-5
mol/L) in the suffusate. The slopes of regression lines are
significantly different (P<.05): control, y=0.76x+55.4 (r=.98);
INDO, y=0.19x+55.1 (r=.960). *Significant changes from con-
trol (P<.05).
different in SH compared with NW rats (Table).
L-NNA inhibited nitric oxide synthase, as indicated by
the significant suppression of the dilation to acetylcho-
line but not to sodium nitroprusside in both strains of
rats (Table). L-NNA also significantly reduced the basal
Effect of L-NNA and Indomethacin on Arteriolar Responses to Various Agents in NW
and SH Rats
Conditions Strain ACh SNP AA PGE2
Control NW 32.8+1.6 26.9+3.4 22.2+1.8 22.4±2.4
SH 31.4±1.8 22.3±0.8 22.8+1.0 24.1±3.4






Data are mean+SEM of percent changes in arteriolar diameter in response to acetylcholine (ACh,
1o8 mol/L), sodium nitroprusside (SNP, 10-7 mol/L), arachidonic acid (AA, 10-5 mol/L), and
prostaglandin E2 (PGE2, 10- mol/L) in control and after treatment with N'~-nitro-L-arginine (L-NNA,
10-4 mol/L) and indomethacin (Indo, 10-5 mol/L) of normal Wistar (NW; N=6/n=7) and spontaneously
hypertensive (SH; N=7/n=7) rats. *Significant changes from control (P<.05).
4[
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FIG 3. Top, Graph showing arteriolar diameter (mean+±SEM) of
normotensive Wistar rat gracilis arterioles (N [rats]=6/n [ves-
sels] =7) as a function of perfusate flow in control conditions, in
the presence of Na@-nitro-L-arginine (L-NNA, 10-4 mol/L), and in
the simultaneous presence of L-NNA and indomethacin (INDO)
in the suffusate. The slopes of the regression lines are signifi-
cantly different (P<.05): control, y=1.6x+56.6 (r=.999); L-NNA,
y=1.1x+49.5 (r=.986); L-NNA+INDO, y=0.09x+44.8 (r=.947).
Bottom, Graph showing changes in diameter (mean±SEM) of
spontaneously hypertensive rat gracilis arterioles (N=7/n=7) as
a function of perfusate flow in control conditions, in the presence
of L-NNA (10-4 mol/L), and in the presence of L-NNA and INDO.
The slope of the regression line of L-NNA+INDO is significantly
different from control and from L-NNA, above. Control,
y=0.78x+48.1 (r=.987); L-NNA, y=0.80x+45.1 (r=.995);
L-NNA+INDO, y=0.05x+39.0 (r=.864). *Significant changes
from control; #significant changes from both control and L-NNA
(P<.05).
diameter of arterioles in a similar manner in both
strains of rats (by z9% and =6% in NW and SH rats,
respectively).
In normotensive rats, L-NNA significantly reduced
flow-induced arteriolar dilation (Fig 3, upper panel).
For example, at 25-,tL/min flow, the diameter of
L-NNA-treated arterioles of NW rats was =43% less
than that of control. Also, the slopes of flow-diameter
curves were significantly different in the control condi-
tion and in the presence of L-NNA. In contrast, in
arterioles of SH rats, L-NNA did not significantly affect
the arteriolar dilation in response to step increases in
perfusate flow (Fig 3, lower panel). In the presence of
L-NNA, administration of indomethacin caused an
additional decrease in basal diameter (by =20%), elic-
ited a further significant reduction of flow-induced
responses in normotensive rats, aqd practically elimi-
nated the dilation to increases in perfusate flow in SH
rats (Fig 3). Thus, the inhibitory effect of indomethacin
on flow-induced arteriolar dilation was observed both in
the presence and the absence of L-NNA and in both
NW and SH rats (Figs 2 and 3).
Discussion
The salient finding of this study is that in young,
spontaneously hypertensive rats, the flow-dependent
dilation of arterioles is significantly reduced compared
with that of normotensive rats. This reduced response to
flow seems to be due primarily to the impairment of the
nitric oxide-mediated portion of flow-dependent
dilation.
Previous investigation of the microcirculation of hy-
pertensive animals revealed morphological changes in
the vascular wall as well as changes in the structure of
the arteriolar network.1-4 These changes were used to
explain the enhanced peripheral resistance that accom-
panies hypertension.3 Recent studies, however, support
the idea that an altered function of vascular endothelial
cells is intimately involved in the development of hyper-
tension. For example, studies of ring preparations of rat
aorta6 and mesenteric arteries78 of hypertensive ani-
mals demonstrated that responses to the endothelium-
dependent dilator agent acetylcholine were reduced or
reversed to constriction, whereas those to endothelium-
independent dilator agents remained unaltered. It was
also shown that the changes in the function of endothe-
lium of large vessels in hypertension might be linked to
changes in the synthesis of nitric oxide or arachidonic
acid metabolites or the production of superoxide an-
ions.7?22 Only a few studies, however, suggest a possible
role for the altered function of microvascular endothe-
lium in the development of hypertension.
It was suggested previously that endothelium can
contribute to circulatory homeostasis by the shear
stress-dependent regulation of vascular resistance that
can be stimulated by increases in blood flow.'823 Flow-
dependent dilation of arterioles has not yet been inves-
tigated in hypertension, preventing the assessment of
the importance of this mechanism in the development of
the chronic elevation of blood pressure. Therefore, the
question that our study addressed was whether alter-
ations in the function of arteriolar endothelium and/or
smooth muscle affect the magnitude of flow-induced
dilation in isolated arterioles of young, genetically hy-
pertensive rats.
Arterioles of rat gracilis muscle were chosen for the
present study because the microcirculation of skeletal
muscle is responsible for a sizable fraction of peripheral
resistance.24 Also, we used second-order arterioles, ves-
sels in which the elevation of intravascular pressure in
hypertension is likely to be less than in larger arterioles
and arteries.25,26 As a control, we used NW rats because
in preliminary studies we found that gracilis muscle
arterioles of Wistar-Kyoto rats responded poorly or not
at all to a variety of vasoactive stimuli and as such could
not be used as the appropriate control for SH rats.27,28
To avoid the interference of other local mechanisms
that regulate arteriolar diameter, the presence of and
changes in flow-dependent responses were investigated
in isolated cannulated arterioles in the presence of
constant intravascular pressure.17 To minimize struc-
tural changes in the arteriolar wall, we used relatively
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already have a significantly elevated systemic blood
pressure.
We found that the active and passive diameters of
arterioles of NW rats were slightly larger than those of
SH rats, but only the passive diameters of NW and SH
rats differed significantly. Also, the magnitude of the
myogenic tone in normotensive and hypertensive graci-
lis arterioles was similar (=51% of passive diameter).
These findings are in accord with in vivo data obtained
in cremasterl2,25,26 and spinotrapezius29 muscle of nor-
motensive and hypertensive rats, tissues in which no
significant differences in average basal diameter of
arterioles were found, corresponding with the finding
that blood pressure is close to normal in small arterioles
of hypertensive rats.
Impairment of Flow-Induced Dilation
in Hypertension
In response to increases in perfusate flow, arterioles
of hypertensive rats exhibited a reduced dilation com-
pared with normotensive rats, as indicated by the sig-
nificant shift in the slope of the flow-diameter curves of
SH arterioles compared with those of NW arterioles
(Fig 1). Similar conclusions were reported in human
coronary30 but not in the brachial3' circulation of pa-
tients with essential hypertension. Because previous
studies showed that flow-dependent dilation of skeletal
muscle arterioles is mediated by endothelial fac-
tors,.518,32 we hypothesized that changes in the function
of the endothelium of hypertensive arterioles are re-
sponsible for the observed reduction in flow-induced
dilation. To elucidate the role of endothelial factors in
the mediation of flow-induced dilation in NW and SH
rats, we used inhibitors of nitric oxide16'19-21 and pros-
taglandin synthesis.11-13,18
Role of Nitric Oxide and Prostaglandins in
Flow-Induced Dilation
In normotensive rats, inhibition of either nitric oxide
or prostaglandin synthesis alone significantly reduced
the dilation to flow. Combined application of these two
inhibitors nearly completely eliminated flow-induced
dilation of NW arterioles. These findings demonstrate
that in arterioles of rat gracilis muscle, both nitric oxide
and prostaglandins are involved in the endothelial me-
diation of dilation after increases in perfusate flow.32 In
gracilis muscle arterioles, this proportion seems to be
=41% and =48%, respectively, accounting nearly com-
pletely for the mediation of the response.
Lack of Nitric Oxide-Mediated Dilation to Flow in
Hypertensive Rats
In hypertensive rats, in which the flow-induced dila-
tion is already reduced compared with normotensive
rats, inhibition of nitric oxide synthase by L-NNA did
not further reduce the flow-induced response, whereas
indomethacin treatment nearly completely eliminated
the impaired flow-induced dilation. These findings sug-
gest that in hypertensive arterioles increases in perfus-
ate flow do not elicit a nitric oxide-mediated dilation
but do stimulate the synthesis of prostaglandins that are
responsible for the remaining dilation in response to
increases in flow.
In contrast to the impaired flow-induced dilation, we
oles to acetylcholine and arachidonic acid, responses that
are mediated by endothelium-derived nitric oxide and
prostaglandins,"1-"320 respectively. Arteriolar responses
to sodium nitroprusside and prostaglandin E2 were also
not affected in SH rats. These findings indicate that
agonist-induced endothelium-derived relaxing factor/ni-
tric oxide and prostaglandin synthesis is preserved in
arterioles of young SH rats. Interestingly, in Dahl hyper-
tensive rats arterioles of rat spinotrapezius muscle
showed an impairment in the basal release of nitric oxide
in resting flow conditions but no appreciable change in
the dilator response to acetylcholine.9 In static flow
conditions in the present in vitro study, we found a
similar effect of inhibitors of either nitric oxide or pros-
taglandin synthesis on the diameter of NW and SH
arterioles.
Our findings support the hypothesis that in skeletal
muscle arterioles of young genetically hypertensive rats,
the endothelial synthesis of nitric oxide to agonists is
preserved but the sensitivity of arterioles to flow (shear
stress), coupled to the synthesis of nitric oxide, is
impaired. It is quite possible that this early change in
the vasoactive function of arteriolar endothelium pre-
cedes the structural changes of the arteriolar wall in
various forms of hypertension, similar to what was
suggested in a recent study of the function of arterial
endothelium of prehypertensive SH rats.22 The reason
for the observed changes, therefore, could be geneti-
cally determined or a result of the prevailing hemody-
namic conditions33 (increased flow velocity or pressure,
etc) to which these arterioles are exposed in hyperten-
sion. Whatever the reason, it seems that in hypertension
there is an impairment in the "rheoreceptors" that link
the increase in shear stress to nitric oxide synthesis but
not in those that link it to prostaglandin synthesis.
Previous studies indicate that increases in flow may
activate a potassium channel that is coupled to a
pertussis toxin-sensitive G protein, eliciting enhanced
nitric oxide synthesis.34-36 Therefore, it is tempting to
speculate that perhaps this pathway of signal transduc-
tion is impaired in hypertension.
Effect of Impaired Flow-Induced Dilation
on Autoregulation
Two of the important vascular mechanisms that reg-
ulate arteriolar diameter are stimulated by the changes
in pressure and flow (shear stress). Because they have
opposite effects on diameter, they are able to maintain
an adequate vascular resistance. The impairment of
flow-dependent dilation in hypertension could result in
an imbalance of these mechanisms favoring the devel-
opment of a positive feedback cycle to promote (togeth-
er with other abnormal mechanisms) increases in arte-
riolar resistance. Such an increase in vascular tone may
also be responsible for functional rarefaction observed
in skeletal muscle microcirculation in hypertension.1-3 It
is likely that changes similar to those described here
occur in arterioles of a variety of vascular beds. There-
fore, the lack of a nitric oxide-mediated flow sensitivity
in hypertension can, via an increase in peripheral resis-
tance, predispose the circulatory system to an elevation
of blood pressure,37 regardless of whether this mecha-
nism is a target or a cause of hypertension.
In conclusion, the present study is the first to dem-
found no significant impairment in dilation of SH arteri- onstrate a reduced flow-induced dilation of arterioles of
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genetically hypertensive rats; this reduction is due to an
impairment of the nitric oxide-mediated flow-depen-
dent dilation, whereas the prostaglandin-mediated por-
tion of the dilation seems to be intact. Thus, the present
findings suggest an important role for the altered vaso-
active function of arteriolar endothelium in skeletal
muscle arterioles in the pathogenesis of hypertension.
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